Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Reference Laboratories Inc Reaffirms FY 2012 Guidance-Conference Call


Thursday, 6 Dec 2012 10:30am EST 

Bio-Reference Laboratories Inc re-affirmed fiscal 2012 guidance that it gave earlier in the year of an increase in net revenues by more than 15% and net income by around 20% for fiscal 2012. The Company reported revenue of $558.64 million and net profit of $32.63 in fiscal 2011. According to I/B/E/S estimates, analysts were expecting the Company to report revenue of $638 million and net income of $38.23 for fiscal 2012. 

Company Quote

30.06
0.13 +0.43%
2:18pm EDT